In our study, altered G0S2 expression in CML changed the expression of di‐ and tri‐glycerides, but also several glycerophospholipids, including phosphatidylcholine and phosphatidylethanolamine (Figure 7). Here, G0S2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.